| 心房颤动处理策略上的一些新认识 |
| |
| 引用本文： | 黄永麟,陈桂英. 心房颤动处理策略上的一些新认识[J]. 医学与哲学(人文社会医学版), 2011, 0(4): 51-52 |
| |
| 作者姓名： | 黄永麟 陈桂英 |
| |
| 作者单位： | 哈尔滨医科大学附属第一医院,黑龙江哈尔滨150001 |
| |
| 摘 要： | 阐述近年来对心房颤动部分处理方法的新进展。心室率控制：质疑静息中或剧烈活动时严格控制心室率,引用RACE2研究,提出宽松的心率控制,其预后与严格控制的相仿。药物转复房颤：首选为胺碘酮,决奈达龙已获FDA批准用于非永久性房颤,伊布利特近年提出在射频消融过程中应用,可使心房碎裂波区缩小,消融易成功。其他新药尚无临床确切疗效...
|
| 关 键 词： | 心房颤动 心室率控制 药物转复房颤 抗凝治疗 |
Some New Understandings in Treatment with Atrial Fibrillation |
| |
| HUANG Yong-lin,CHEN Gui-ying. Some New Understandings in Treatment with Atrial Fibrillation[J]. Medicine & Philosophy:Humanistic & Social Medicine Edition, 2011, 0(4): 51-52 |
| |
| Authors: | HUANG Yong-lin CHEN Gui-ying |
| |
| Affiliation: | .The First Affiliated Hospital of Harbin Medical University,harbin 150001,China |
| |
| Abstract: | This paper is to expound new progression in atrial fibrillation processing in recent years.Ventricular rate control： RACEⅡ research proposed that it is similar between lenient heart rate controlling and strictly controlling in prognosis.So strictly controlling the ventricular rate is questioning.Drug converting atrial fibrillation： first choice for Amiodarone,Dronedarone has been approved by FDA for the nonpermanent AF,Ibutilide in recent years is put forward in radiofrequency ablation,CFAE narrowing can make ablation is easy to succeed.Other drugs there had been no clinical exactly curative effect.Anticoagulation： still recommended for Warfarin.Xa inhibitor has been seriously consideration.Many new preparations still need clinical observation,to determine the interaction with other drugs,etc. |
| |
| Keywords: | atrial fibrillation ventricular rate control drug converting atrial fibrillation anticoagulation |
| 本文献已被 维普 等数据库收录！ |
|
